130 related articles for article (PubMed ID: 7246128)
1. Phenytoin and IgA concentrations in plasma and saliva in epileptic children.
Modéer T; Tomson G; Falk O; Rane A
Acta Paediatr Scand; 1981; 70(3):373-8. PubMed ID: 7246128
[TBL] [Abstract][Full Text] [Related]
2. Phenytoin-valproate interaction: importance of saliva monitoring in epilepsy.
Knott C; Hamshaw-Thomas A; Reynolds F
Br Med J (Clin Res Ed); 1982 Jan; 284(6308):13-6. PubMed ID: 6797618
[TBL] [Abstract][Full Text] [Related]
3. Phenytoin-induced depression of salivary IgA.
Aarli JA
Acta Otolaryngol; 1976; 82(3-4):199-201. PubMed ID: 983675
[No Abstract] [Full Text] [Related]
4. Phenytoin-induced depression of salivary IgA and gingival hyperplasia.
Aarli JA
Epilepsia; 1976 Sep; 17(3):283-91. PubMed ID: 976219
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin A levels in serum and saliva of patients treated with phenytoin.
Akalin FA; Yavuzyilmaz E; Ersoy F; Kalfa Z; Müftüoglu M
J Nihon Univ Sch Dent; 1993 Mar; 35(1):10-5. PubMed ID: 8326368
[TBL] [Abstract][Full Text] [Related]
6. Salivary phenytoin concentrations in epilepsy and in chronic renal failure.
Reynolds F; Ziroyanis PN; Jones NF; Smith SE
Lancet; 1976 Aug; 2(7982):384-6. PubMed ID: 73850
[TBL] [Abstract][Full Text] [Related]
7. Comparison of phenytoin determinations in plasma, plasma dialysate and saliva for control of antiepileptic therapy in children.
Brügmann G; Kleinau E; Nolte R; Petruch F
Klin Wochenschr; 1979 Jan; 57(2):93-4. PubMed ID: 762949
[TBL] [Abstract][Full Text] [Related]
8. Changes in serum immunoglobulin levels during phenytoin treatment of epilepsy.
Aarli JA
Acta Neurol Scand; 1976 Nov; 54(5):423-30. PubMed ID: 998166
[TBL] [Abstract][Full Text] [Related]
9. Monitoring phenytoin in salivary and plasma ultrafiltrates of pediatric patients.
Bachmann K; Forney RB; Voeller K
Ther Drug Monit; 1983; 5(3):325-9. PubMed ID: 6636260
[TBL] [Abstract][Full Text] [Related]
10. Phenytoin and phenobarbital concentrations in saliva and plasma measured by radioimmunoassay.
Cook CE; Amerson E; Poole WK; Lesser P; O'Tuama L
Clin Pharmacol Ther; 1975 Dec; 18(6):742-7. PubMed ID: 1204279
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulins in epilepsy.
Bassanini M; Baez A; Sotelo J
J Neurol Sci; 1982 Nov; 56(2-3):275-81. PubMed ID: 7175551
[No Abstract] [Full Text] [Related]
12. Drug-induced IgA deficiency in epileptic patients.
Aarli JA
Arch Neurol; 1976 Apr; 33(4):296-9. PubMed ID: 1259644
[TBL] [Abstract][Full Text] [Related]
13. A correlation between the levels of phenobarbital, phenytoin and valproic acid in the blood serum and in saliva from children treated due to epilepsy.
Sobaniec W
Mater Med Pol; 1989; 21(4):323-6. PubMed ID: 2489248
[TBL] [Abstract][Full Text] [Related]
14. Salivary and plasma IgA of seizure subjects receiving phenytoin.
Smith QT; Hamilton MJ; Biros MH; Pihlstrom BL
Epilepsia; 1979 Feb; 20(1):17-23. PubMed ID: 421674
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin G in serum and cerebrospinal fluid from epileptic patients treated with phenytoin.
Fossan GO; Aarli JA
Eur Neurol; 1979; 18(5):322-7. PubMed ID: 527607
[TBL] [Abstract][Full Text] [Related]
16. Salivary immunoglobulin concentrations in patients with epilepsy treated with carbamazepine.
Gilhus NE; Strandjord RE; Aarli JA
Acta Neurol Scand; 1980 Nov; 62(5):300-4. PubMed ID: 7468153
[TBL] [Abstract][Full Text] [Related]
17. IgA deficiency, epilepsy, and phenytoin treatment.
Seager J; Jamison DL; Wilson J; Hayward AR; Soothill JF
Lancet; 1975 Oct; 2(7936):632-5. PubMed ID: 52004
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of phenobarbitone and phenytoin therapy in small children by salivary samples.
Mucklow JC; Bacon CJ; Hierons AM; Webb JK; Rawlins MD
Ther Drug Monit; 1981; 3(3):275-7. PubMed ID: 7324092
[TBL] [Abstract][Full Text] [Related]
19. Salivary phenytoin levels in institutionalized epileptics.
Hassell T; O'Donnell J; Pearlman J; Tesini D; Best H; Murphy T
J Chronic Dis; 1983; 36(12):899-906. PubMed ID: 6655035
[TBL] [Abstract][Full Text] [Related]
20. Plasma and saliva concentrations of phenytoin and 5-(4-hydroxyphenyl)-5-phenylhydantoin in relation to the incidence and severity of phenytoin-induced gingival overgrowth in epileptic patients.
Ball DE; McLaughlin WS; Seymour RA; Kamali F
J Periodontol; 1996 Jun; 67(6):597-602. PubMed ID: 8794970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
